Vanda Pharmaceuticals (VNDA) EPS (Basic) Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -64.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.00% |
| Dec 31, 2025 | -2,555.56% |
| Sep 30, 2025 | -322.22% |
| Jun 30, 2025 | -475.00% |
| Mar 31, 2025 | -614.29% |
| Dec 31, 2024 | -80.00% |
| Sep 30, 2024 | -3,866.20% |
| Jun 30, 2024 | -366.67% |
| Mar 31, 2024 | -216.67% |
| Dec 31, 2023 | -141.67% |
| Sep 30, 2023 | -96.02% |
| Jun 30, 2023 | -40.00% |
| Mar 31, 2023 | 154.55% |
| Dec 31, 2022 | -7.69% |
| Sep 30, 2022 | -57.14% |
| Jun 30, 2022 | -70.59% |
| Mar 31, 2022 | -168.75% |
| Dec 31, 2021 | -13.33% |
| Sep 30, 2021 | 27.27% |
| Jun 30, 2021 | 6.25% |
| Mar 31, 2021 | 1,500.00% |
| Dec 31, 2020 | 87.50% |
| Sep 30, 2020 | -94.15% |
| Jun 30, 2020 | -27.27% |
| Mar 31, 2020 | 200.00% |
| Dec 31, 2019 | -60.00% |
| Sep 30, 2019 | 1,242.86% |
| Jun 30, 2019 | 144.44% |
| Mar 31, 2019 | -114.29% |
| Dec 31, 2018 | 600.00% |
| Sep 30, 2018 | 240.00% |
| Jun 30, 2018 | 400.00% |
| Mar 31, 2018 | 141.18% |
| Dec 31, 2017 | -300.00% |
| Sep 30, 2017 | -900.00% |
| Jun 30, 2017 | 72.73% |
| Mar 31, 2017 | 41.38% |
| Dec 31, 2016 | 97.06% |
| Sep 30, 2016 | 95.45% |
| Jun 30, 2016 | 15.38% |
| Mar 31, 2016 | -20.83% |
| Dec 31, 2015 | -118.38% |
| Sep 30, 2015 | -450.00% |
| Jun 30, 2015 | 79.69% |
| Mar 31, 2015 | 69.62% |
| Dec 31, 2014 | 904.35% |
| Sep 30, 2014 | 76.47% |
| Jun 30, 2014 | -433.33% |
| Mar 31, 2014 | -393.75% |
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | 10.53% |
| Jun 30, 2013 | 57.14% |
| Mar 31, 2013 | 42.86% |
| Dec 31, 2012 | -15.00% |
| Sep 30, 2012 | -72.73% |
| Jun 30, 2012 | -460.00% |
| Mar 31, 2012 | -5,885.59% |
| Dec 31, 2011 | -350.00% |
| Sep 30, 2011 | -200.00% |
| Jun 30, 2011 | -200.00% |